U.S. seaborne imports of pharmaceuticals dipped by 1.8% in the first half of July versus June on a daily average basis, even as the caseload from COVID-19 continued to increase. Policies for the sourcing of pharmaceuticals may become a focus for the general election. President Trump has issued a set of Executive Orders that will promote increased imports. The campaign of Vice President Biden has outlined a strategy to use the Defense Production Act, federal purchasing and the tax code to bolster domestic production of key drugs. The sequential dip in U.S. seaborne imports in July has bee...